TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05256914

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ozoral Pro and Ozoral gel administration
Description: Peri-implant mucositis sites will receive in-office Ozoral Pro administration after non-surgical therapy. Patients will use Ozoral Gel for the domiciliary administration once a day for 14 days after the visits (no rinsing and eating for 30 minutes after gel application).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Curasept chlorhexidine gel 1%
Description: Peri-implant mucositis sites will receive in-office Curasept chlorhexidine gel 1% administration after non-surgical therapy. Patients will use chlorhexidine gel 1% for the domiciliary application once a day for 14 days after the visits (no rinsing and eating for 30 minutes after gel application).
Study: NCT05128539

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS001(Toripalimab)+JS002
Description: Part A: In this phase, 3 dose levels will be preliminarily set up. The dose level of Toripalimab is fixed as 240 mg, intravenous infusion, Q3W. The dose levels of JS002 are fixed at 75 mg,150 mg and 300 mg subcutaneously, and the traditional 3+3 design will be used for dose escalation with 21 days as entire treatment cycle. In addition, the period of 21 days after the first administration is defined as the DLT observation period.~Part B: Based on the data of the safety, PK and preliminary efficacy in Part A patients, the dosage will be determined for advanced tumor patients who had received at least first-line therapy in this part. Two to three groups with different tumor types will be further enrolled, and about 30 patients will be included in each group (the specific number and cohort will be adjusted according to the research progress). Toripalimab is a humanized IgG4κ mAb specific against human PD-1.
Study: NCT06379451

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NKG2D Chimeric Antigen Receptor NK Cell Injection
Description: Administer KN1102 cell injection three times on day 0, day 7, and day 14, respectively.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NKG2D Chimeric Antigen Receptor NK Cell Injection
Description: Administer KN1102 cell injection three times on day 0, day 7, and day 14, respectively.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NKG2D Chimeric Antigen Receptor NK Cell Injection
Description: Administer KN1102 cell injection three times on day 0, day 7, and day 14, respectively.
Study: NCT04827602

Intervention type: OTHER
Intervention: Drug allergy label status in electronic health records
Description: Registered drug allergy labels in primary care and hospital electronic medical charts
Study: NCT06170931

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: posterior cruciate ligament-retaining prostheses
Description: Posterior cruciate ligament protective approach in patients with knee osteoarthritis

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: posterior cruciate ligament-substituting prostheses
Description: Posterior cruciate ligament transection approach in patients with knee osteoarthritis
Study: NCT05476978

Intervention type: DIAGNOSTIC_TEST
Intervention: EUS-AI model
Description: The test subset (approximately 20% of total patients) is reserved for the final evaluation of the EUS-AI model. Clinical parameters and EUS pictures of each patient in the test subset will be inputed into the trained EUS-AI model, and the most possible diagnosis will be given by the model.
Study: NCT06512181

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conservative/Expectant Management
Description: At time of caesarean section, participants will not have a hysterectomy, but will be treated clinically to preserve their uterus.
Study: NCT06345924

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MERAKI_PC
Description: The three music therapy sessions focus on helping the patient to adjust to their situation. The aim is to provide emotional support and encourage communication between family members through music. In addition, the therapy will help the patient to appreciate their remaining abilities and encourage their involvement in the rehabilitation process. The second session focuses on living in the present through re-identification. The session aims to improve the symptoms associated with the illness by focusing on the present situation and encouraging expression.~The main aim of the final session, 'The Journey of Life - Leaving a Mark', is to recapitulate and provide support.~Songs are used during the session, taking into account musical preferences.
Study: NCT06529068

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Isometric handgrip exercise
Description: The participants will perform isometric handgrip exercises without blood flow restriction.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise with a narrow-elastic band
Description: The participants will perform isometric handgrip exercises with blood flow restriction using a narrow-elastic band.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise with a wide-rigid cuff
Description: The participants will perform isometric handgrip exercises with blood flow restriction using a wide-rigid cuff.
Study: NCT05693181

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Multiple systemic (i.v.) administration of allogenic non-related group- and rhesus-compatible mononuclear cord blood cells
Description: Each HUCBCs sample contain 500 +/- 50 x 10\*6 allogenic non-related group- and rhesus-compatible mononuclear cord blood cells

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control vehicle (sterile saline)
Description: Sterile saline infusion in control patients
Study: NCT06024928

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control-IQ use in Type 2 Diabetes under basal insulin injections
Description: Testing the safety and feasibility of using Automated Insulin Delivery (AID) in people with Type 2 Diabetes under basal insulin injections to achieve safe and fast basal insulin titration.
Study: NCT05663047

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prevent It 2.0
Description: A free, anonymous, internet-delivered, therapist assisted, cognitive behavioral therapy (CBT) intervention

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Waitlist
Description: Participants in the waitlist control will wait thirteen weeks before starting active treatment. While on the waitlist, participants will respond to questions about ongoing problematic sexual behavior.
Study: NCT06353035

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rewilding
Description: Private yards of the intervention study subjects will be modified with vegetation and deadwood.
Study: NCT05583890

Intervention type: DEVICE
Intervention: Continuous glucose monitors
Description: Participants will wear continuous glucose monitors for a 7 day period.

Intervention type: DEVICE
Intervention: Continuous glucose monitors
Description: Participants will wear continuous glucose monitors for a 7 day period.

Intervention type: DEVICE
Intervention: Continuous glucose monitors
Description: Participants will wear continuous glucose monitors for a 7 day period.

Intervention type: DEVICE
Intervention: Activity tracker
Description: Participants will wear the activity tracker for a 7 day period.

Intervention type: DEVICE
Intervention: Activity tracker
Description: Participants will wear the activity tracker for a 7 day period.

Intervention type: DEVICE
Intervention: Activity tracker
Description: Participants will wear the activity tracker for a 7 day period.

Intervention type: BEHAVIORAL
Intervention: Food Diary
Description: Participants will complete a food diary of everything they eat for 7 days.

Intervention type: BEHAVIORAL
Intervention: Food Diary
Description: Participants will complete a food diary of everything they eat for 7 days.

Intervention type: BEHAVIORAL
Intervention: Food Diary
Description: Participants will complete a food diary of everything they eat for 7 days.

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Participants will complete FACT-Hep, DiPcare-Q and health inequality related questions.

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Participants will complete FACT-Hep, DiPcare-Q and health inequality related questions.

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Participants will complete FACT-Hep, DiPcare-Q and health inequality related questions.
Study: NCT05238285

Intervention type: BEHAVIORAL
Intervention: Production of vocal sounds
Description: Participants will be asked to produce vocal sounds of different nature according to the non-verbal parameters of interest for the given study.~For example, they can read a script containing vowels ('a', 'e', 'i', 'o', 'u'), short sentences ('hello, how are you'), longer passages of standardised reading texts, and can also be asked to speak freely about any topic ('freedom of speech'). They can be asked to play a role or to imitate a particular emotional state. For example, imagine that you have just been told that you have won a million euros in the lottery. Produce a vocalisation to express your excitement or talk to your dog your dog by imagining that he has done a negative action and then do the same thing by imagining that this time imagining that the action was positive.
Study: NCT06195150

Intervention type: OTHER
Intervention: Blood collection
Description: 15ml of blood are harvested before surgery
Study: NCT05935982

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual reality exercise
Description: During school special physical education, participants will be asked to exercise using a virtual reality exercise headset, that will be adapted for arm use. Participants will asked to be seated during gameplay. Heart rate will be monitored and recorded during exercise.
Study: NCT06283381

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Description: oral administration, tablets, 40 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esomeprazole
Description: oral administration, tablets, 40 mg
Study: NCT06134310

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fascial Distortion Model
Description: The following techniques were used on the cranial and cervical areas during therapy: Trigger band technique, herniated trigger point technique, continuum technique, folding technique, cylinder technique, and tectonic technique.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Core Stabilization Training
Description: Week 1st (1 x 10 reps): Supine deep cervical activation, supine deep lumbar activation, prone deep cervical activation, prone deep lumbar activation, supine combined deep cervical and lumbar activation, and prone combined deep cervical and lumbar activation; Week 2nd (1 x 10 reps): Arm openings, hundreds 1, one leg stretch 1, double leg stretch 1, shoulder bridge, breaststroke, leg pull prone prep 1; Week 3rd (1 x 10 reps): Arm openings, hundreds 2, one leg stretch 2, double leg stretch 2, shoulder bridge, breaststroke, leg pull prone prep 2; Week 4th (1 x 10 reps): Arm openings, hundreds 2, one leg stretch 2, double leg stretch 3, shoulder bridge, breaststroke, leg pull prone prep 2; Week 5th to 8th (with Resistance Band; 1 x 10 reps): Arm openings, shoulder bridge, swan dive, scapula isolations, plough, biceps curl, roll up, roll up with biceps, roll up with rowing, seated spine twist, swimming in kneeling, one leg kick in kneeling and diamond press in standing

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rocabado's 6x6 Exercises
Description: Resting position of the tongue, rotational control of temporomandibular joint, rhythmic stabilization, axial extension of the neck, shoulder posture, and stabilized head flexion
Study: NCT06574867

Intervention type: DEVICE
Intervention: viQtor Wearable Monitoring Device
Description: The viQtor device is a wearable medical device designed for continuous monitoring of vital signs, including heart rate (PR), respiratory rate (RR), and blood oxygen saturation (SpO2). It is worn on the upper arm and transmits data wirelessly to a cloud-based platform. This device is being evaluated as part of the standard monitoring protocol for post-operative patients in a surgical ward setting.
Study: NCT06134310

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Rocabado's 6x6 Exercises
Description: Resting position of the tongue, rotational control of temporomandibular joint, rhythmic stabilization, axial extension of the neck, shoulder posture, and stabilized head flexion

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Education
Description: Participants are instructed to perform some behaviors while avoiding others based on the etiology of temporomandibular disorders.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Education
Description: Participants are instructed to perform some behaviors while avoiding others based on the etiology of temporomandibular disorders.
Study: NCT05906264

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tele-intervention
Description: Tele-intervention every week to check compliance and encourage the rehabilitation
Study: NCT05639569

Intervention type: DEVICE
Intervention: Ankura™ TAA Stent Graft System
Description: All patients will be implanted with Ankura™ TAA Stent Graft System in accordance with the instructions for use (IFU).
Study: NCT05941507

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LCB84
Description: TROP2-directed human monoclonal antibody (Ab) linked to a monomethyl auristatin E (MMAE) prodrug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LCB84
Description: TROP2-directed human monoclonal antibody (Ab) linked to a monomethyl auristatin E (MMAE) prodrug

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 monoclonal antibody
Description: anti-PD-1 Ab
Study: NCT05790681

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin icodec
Description: Participants will receive subcutaneously fixed dose of insulin icodec (700 U/mL) that is 5.6 U/kg bodyweight.
Study: NCT05655364

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile application
Description: Breastfeeding Supportive Mobile Application
Study: NCT04916860

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Senl-T7
Description: Patients will be treated with CD7 CAR-T cells
Study: NCT05427331

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FMT capsule
Description: Patients with insomnia need to take FMT capsules orally in an empty stomach in the morning, 16 capsules once a week, for 4 consecutive weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: FMT capsule
Description: Patients with insomnia need to take FMT capsules orally in an empty stomach in the morning, 16 capsules once a week, for 4 consecutive weeks
Study: NCT06057246

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test meal with postprandial samples
Description: The mixed-nutrient test meal consists of a sandwich made with bread, spread cheese, air-cured beef, and one apple. Nutritional composition of the meal will be: total energy (TE) content 532 kcal, carbohydrates 68,4 g (49.3% TE), total fat 17.1 g (29.5% TE), protein 27.8 g (21.4% TE), and fibre 6 g. Before and over 4 hours after the meal, venous blood samples will be taken for biochemical evaluations at the time points -15'; 0'; 15'; 30'; 60'; 120'; 180'; 240'.
Study: NCT04762745

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide( Anyue®, Chia Tai TIANQING, China), 4mg, orally(PO), d1-21, 28d/cycle, 1cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Bendamustine( Leweixin®, Chia Tai TIANQING, China), 60mg/m2/d, intravenously(IV), d1-2, 28d/cycle, 1 cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone, 40mg, PO or IV, d1, 8, 15, 22, 28d/cycle, 1 cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide( Anyue®, Chia Tai TIANQING, China), 4mg, orally(PO), d1-21, 28d/cycle, 1cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Bendamustine( Leweixin®, Chia Tai TIANQING, China), 70mg/m2/d, intravenously(IV), d1-2, 28d/cycle, 1 cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone, 40mg, PO or IV, d1, 8, 15, 22, 28d/cycle, 1 cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide( Anyue®, Chia Tai TIANQING, China), 4mg, orally(PO), d1-21, 28d/cycle, 1cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Bendamustine( Leweixin®, Chia Tai TIANQING, China), 70mg/m2/d, intravenously(IV), d1-2, 28d/cycle, 1 cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone, 40mg, PO or IV, d1, 8, 15, 22, 28d/cycle, 1 cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Pomalidomide( Anyue®, Chia Tai TIANQING, China), 4mg, orally(PO), d1-21, 28d/cycle, 8 cycles. Then pomalidomide( Anyue®, Chia Tai TIANQING, China), 4mg, orally(PO), d1-21, 28d/cycle until progression or intolerable toxicities.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: Bendamustine( Leweixin®, Chia Tai TIANQING, China), 70mg/m2/d, intravenously(IV), d1-2, 28d/cycle, 8 cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone, 40mg, PO or IV, d1, 8, 15, 22, 28d/cycle, 8 cycles. Then dexamethasone, 40mg, PO or IV, d1, 8, 15, 22, 28d/cycle until progression or intolerable toxicities.
Study: NCT04841057

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 50 cm BP limb length
Description: 50 cm biliopancreatic limb length

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 100 cm BP limb length
Description: 100 cm biliopancreatic limb length
Study: NCT05658445

Intervention type: OTHER
Intervention: evacuation
Description: after complete evacuation of uterus follow abortion

Intervention type: OTHER
Intervention: evacuation
Description: after complete evacuation of uterus follow abortion
Study: NCT05791305

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: double duty intervention packages
Description: The intervention employed in this study will serve as double-duty interventions. The WHO policy short report from 2017 and Hawkes et al2020 .'s were amended and used as the basis for the DDIs packages. The main components of the intervention packages are the promotion of a minimum level of dietary diversity, avoiding unwarranted harm from high-energy foods, and controlling market foods from the perspective of the consumer. The following central criteria will be used to evaluate the study's intervention packages.
Study: NCT06646835

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Ball Intervention
Description: The stress ball is a simple and effective tool for reducing anxiety and relaxation as a non-pharmacological method (Yanes et al., 2018). Due to the limited pharmacological options available for pregnant women to reduce anxiety during cesarean section, alternative, complementary or supportive non-pharmacological methods and low-risk approaches are needed (Baltacı \& Başer, 2020). It is thought that squeezing the stress ball may be advantageous in reducing anxiety.
Study: NCT04841057

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 150 cm BP limb length
Description: 150 cm BP limb length
Study: NCT05108337

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block
Description: Ultrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml 0.5% ropinacaine.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control group
Description: Ultrasound guidance will be used to determine the location of superficial cervical plexus nerve. The puncture will also be performed by ultrasound guidance, covered with opaque infusion dressing but performed with infusion of 10 ml normal saline.
Study: NCT05904847

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Application of The Theory of Planned Behaviour for Diabetes
Description: In the study, diabetes education consisting of a total of 4 sessions structured according to the Planned Behavior Theory will be applied to the intervention group, and a standard diabetes education consisting of a single session containing information about diabetes on the website of the Ministry of Health will be applied to the control group. The training will be given face-to-face in groups of 10-15 people. After the training, the participants will be monitored for 3 months. To increase patient empowerment and self-efficacy, the intervention group will be followed up by phone calls every 15 days to increase motivation and answer questions.
Study: NCT06299397

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: breastfeeding - humor training
Description: Breastfeeding and humor-based practice will continue for 35-45 minutes, once a week for 2 weeks.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control Group
Description: After randomization, consent was obtained from the pregnant women determined that they agreed to participate in the study. The pregnant women in the control group were given a pre-test before starting the study, an interim test 1 month after the start, and a final test 3 months later.
Study: NCT05487872

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mindfulness skills training to reduce experiential avoidance and anxiety symptoms
Description: The intervention aimed to increase participants' mindfulness skills which may be critical in decreasing general experiential avoidance and anxiety symptoms